BioCentury
ARTICLE | Clinical News

Xeomin incobotulinumtoxinA regulatory update

January 9, 2012 8:00 AM UTC

Merz said the Centers for Medicare & Medicaid Services (CMS) issued a permanent J-code for reimbursement of Xeomin incobotulinumtoxinA. J0588, the code for Xeomin, became effective on Jan. 1. The botu...